Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures

Osteoporosis International

Volumn 21, Issue 11, 2010, Pages 1899-1909

  Schousboe, J T ^a,b   Dowd, B E ^a   Davison, M L ^c   Kane, R L ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b PARK NICOLLET INSTITUTE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Concerns about medications; Medication compliance; Medication persistence; Medication use self efficacy; Perceived medication necessity

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; FEMALE; FRACTURE; FRAGILITY FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF REPORT; UNITED STATES;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; BONE DENSITY CONSERVATION AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MINNESOTA; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PATIENT DROPOUTS; SELF EFFICACY; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 77953480148     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-009-1141-5     Document Type: Article

References (43)

1. ND Nguyen HG Ahlborg JR Center JA Eisman TV Nguyen 2007 Residual lifetime risk of fractures in women and men J Bone Miner Res 22 781 788 10.1359/jbmr.070315 17352657 (Pubitemid 351339737)
2. DM Black SR Cummings DB Karpf JA Cauley DE Thompson MC Nevitt DC Bauer HK Genant WL Haskell R Marcus SM Ott JC Torner SA Quandt TF Reiss KE Ensrud 1996 Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group Lancet 348 1535 1541 1:CAS:528:DyaK2sXisFCktQ%3D%3D 10.1016/S0140-6736(96)07088-2 8950879 (Pubitemid 26411651)
3. ST Harris NB Watts HK Genant CD McKeever T Hangartner M Keller CH Chesnut 3rd J Brown EF Eriksen MS Hoseyni DW Axelrod PD Miller 1999 Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group JAMA 282 1344 1352 1:CAS:528:DyaK1MXmvFansr0%3D 10.1001/jama.282.14.1344 10527181 (Pubitemid 29483192)
4. MR McClung P Geusens PD Miller H Zippel WG Bensen C Roux S Adami I Fogelman T Diamond R Eastell PJ Meunier JY Reginster 2001 Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group N Engl J Med 344 333 340 1:CAS:528:DC%2BD3MXht1Wlu7g%3D 10.1056/NEJM200102013440503 11172164 (Pubitemid 32107641)
5. J Reginster HW Minne OH Sorensen M Hooper C Roux ML Brandi B Lund D Ethgen S Pack I Roumagnac R Eastell 2000 Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group Osteoporos Int 11 83 91 1:CAS:528:DC%2BD3cXhvFGgsr0%3D 10.1007/s001980050010 10663363 (Pubitemid 30099515)
6. Wells G, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P (2008) Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev CD004523
7. C MacLean S Newberry M Maglione M McMahon V Ranganath M Suttorp W Mojica M Timmer A Alexander M McNamara SB Desai A Zhou S Chen J Carter C Tringale D Valentine B Johnsen J Grossman 2008 Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis Ann Intern Med 148 197 213 18087050
8. JA Cramer DT Gold SL Silverman EM Lewiecki 2007 A systematic review of persistence and compliance with bisphosphonates for osteoporosis Osteoporos Int 18 1023 1031 1:CAS:528:DC%2BD2sXntVOlsrY%3D 10.1007/s00198-006-0322-8 17308956 (Pubitemid 47019996)
9. P Kothawala E Badamgarav S Ryu RM Miller RJ Halbert 2007 Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis Mayo Clin Proc 82 1493 1501 10.4065/82.12.1493 18053457
10. JA Cramer A Roy A Burrell CJ Fairchild MJ Fuldeore DA Ollendorf PK Wong 2008 Medication compliance and persistence: terminology and definitions Value Health 11 44 47 18237359
11. KF Huybrechts KJ Ishak JJ Caro 2006 Assessment of compliance with osteoporosis treatment and its consequences in a managed care population Bone 38 922 928 10.1016/j.bone.2005.10.022 16330270 (Pubitemid 44498580)
12. JJ Caro KJ Ishak KF Huybrechts G Raggio C Naujoks 2004 The impact of compliance with osteoporosis therapy on fracture rates in actual practice Osteoporos Int 15 1003 1008 10.1007/s00198-004-1652-z 15167989 (Pubitemid 40064656)
13. ES Siris ST Harris CJ Rosen CE Barr JN Arvesen TA Abbott S Silverman 2006 Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases Mayo Clin Proc 81 1013 1022 10.4065/81.8.1013 16901023
14. V Rabenda R Mertens V Fabri J Vanoverloop F Sumkay C Vannecke A Deswaef GA Verpooten JY Reginster 2008 Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women Osteoporos Int 19 811 818 1:CAS:528:DC%2BD1cXltFyjurs%3D 10.1007/s00198-007-0506-x 17999022
15. FE Cotte F Mercier G De Pouvourville 2008 Relationship between compliance and persistence with osteoporosis medications and fracture risk in primary health care in France: a retrospective case-control analysis Clin Ther 30 2410 2422 10.1016/j.clinthera.2008.12.019 19167600
16. R Horne J Weinman M Hankins 1999 The beliefs about medications questionnaire: the development of a new method for assessing the cognitive representation about medication Psychol Health 14 1 24 10.1080/08870449908407311
17. R Horne 1999 Patients' beliefs about treatment: the hidden determinant of treatment outcome? J Psychosom Res 47 491 495 1:STN:280:DC%2BD3c7isFagug%3D%3D 10.1016/S0022-3999(99)00058-6 10661596 (Pubitemid 30029298)
18. R Horne J Weinman 2002 Self-regulation and self-management in asthma: exploring the role of illness perception and treatment beliefs in explaining non-adherence to preventer medication Psychol Health 17 17 32 10.1080/08870440290001502
19. R Horne V Cooper G Gellaitry HL Date M Fisher 2007 Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework J Acquir Immune Defic Syndr 45 334 341 17514019
20. DM Tarn J Heritage DA Paterniti RD Hays RL Kravitz NS Wenger 2006 Physician communication when prescribing new medications Arch Intern Med 166 1855 1862 10.1001/archinte.166.17.1855 17000942 (Pubitemid 44455168)
21. Becker MH, Rosenstock IM (1987) Comparing social learning theory and the health belief model. In: Ward WB (ed) Advances in health behavior and promotion. JAI, Greenwich, pp 245-249
22. A O'Leary 1985 Self-efficacy and health Behav Res Ther 23 437 451 10.1016/0005-7967(85)90172-X 3896228 (Pubitemid 15065517)
23. IM Rosenstock VJ Strecher MH Becker 1988 Social learning theory and the health belief model Health Educ Q 15 175 183 1:STN:280:DyaL1c3ktlCrtQ%3D%3D 3378902
24. H Brus M van de Laar E Taal J Rasker O Wiegman 1999 Determinants of compliance with medication in patients with rheumatoid arthritis: the importance of self-efficacy expectations Patient Educ Couns 36 57 64 1:STN:280: DyaK1M7lsFGrtw%3D%3D 10.1016/S0738-3991(98)00087-1 10036560 (Pubitemid 28535156)
25. MO Johnson TB Neilands SE Dilworth SF Morin RH Remien MA Chesney 2007 The role of self-efficacy in HIV treatment adherence: validation of the HIV treatment adherence self-efficacy scale (HIV-ASES) J Behav Med 30 359 370 10.1007/s10865-007-9118-3 17588200 (Pubitemid 47206606)
26. A Schoenthaler G Ogedegbe JP Allegrante 2009 Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans Health Educ Behav 36 127 137 10.1177/ 1090198107309459 18077654
27. B Resnick L Wehren D Orwig 2003 Reliability and validity of the self-efficacy and outcome expectations for osteoporosis medication adherence scales Orthop Nurs 22 139 147 10.1097/00006416-200303000-00012 12703398
28. Hosmer DW, Lemeshow S (2000) Applied logistic regression. Wiley, New York
29. D Pregibon 1980 Goodness of link tests for generalized linear models Appl Stat 29 15 24 10.2307/2346405
30. RM Baron DA Kenny 1986 The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations J Pers Soc Psychol 51 1173 1182 1:STN:280:DyaL2s7ht1SrsQ%3D%3D 10.1037/0022-3514.51.6.1173 3806354
31. Herr NR (2006) Mediation with dichotomous variables. URL: http://nrherr.bol.ucla.edu/Mediation/logmed.html. Accessed on July 15, 2009
32. DP MacKinnon CM Lockwood JM Hoffman SG West V Sheets 2002 A comparison of methods to test mediation and other intervening variable effects Psychol Methods 7 83 104 10.1037/1082-989X.7.1.83 11928892
33. DP MacKinnon JH Dwyer 1993 Estimating mediated effects in prevention studies Eval Rev 17 144 158 10.1177/0193841X9301700202
34. Schwarzer R, Fuchs R (1995) Self-efficacy and health behaviors. In: Connor M, Norman P (eds) Predicting health behavior. Open University Press, Philadelphia, pp 163-196
35. S Clifford N Barber R Horne 2008 Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the necessity-concerns framework J Psychosom Res 64 41 46 10.1016/j.jpsychores. 2007.05.004 18157998 (Pubitemid 350297299)
36. RR Cline JF Farley RA Hansen JC Schommer 2005 Osteoporosis beliefs and antiresorptive medication use Maturitas 50 196 208 10.1016/j.maturitas.2004.05. 004 15734601 (Pubitemid 40269903)
37. CA McHorney JT Schousboe RR Cline TW Weiss 2007 The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates Curr Med Res Opin 23 3137 3152 1:CAS:528: DC%2BD1cXhslOktr0%3D 10.1185/030079907X242890 17988435
38. EJ Blumberg MF Hovell NJ Kelley AY Vera CL Sipan JP Berg 2005 Self-report INH adherence measures were reliable and valid in Latino adolescents with latent tuberculosis infection J Clin Epidemiol 58 645 648 10.1016/j.jclinepi. 2004.11.022 15878479 (Pubitemid 40692732)
39. PW Choo CS Rand TS Inui ML Lee E Cain M Cordeiro-Breault C Canning R Platt 1999 Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy Med Care 37 846 857 1:STN:280:DyaK1MvitFajtQ%3D%3D 10.1097/00005650-199909000-00002 10493464
40. KC Farmer 1999 Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice Clin Ther 21 1074 1090 1:STN:280:DyaK1Mzmslansg%3D%3D 10.1016/S0149-2918(99)80026-5 10440628 discussion 1073 (Pubitemid 29326165)
41. MC Garber DP Nau SR Erickson JE Aikens JB Lawrence 2004 The concordance of self-report with other measures of medication adherence: a summary of the literature Med Care 42 649 652 10.1097/01.mlr.0000129496.05898.02 15213489
42. RB Haynes DW Taylor DL Sackett ES Gibson CD Bernholz J Mukherjee 1980 Can simple clinical measurements detect patient noncompliance? Hypertension 2 757 764 1:STN:280:DyaL3M7hs1aktA%3D%3D 7007235
43. BJ Mason JR Matsuyama SG Jue 1995 Assessment of sulfonylurea adherence and metabolic control Diabetes Educ 21 52 57 1:STN:280:DyaK2M7js1ygug%3D%3D 10.1177/014572179502100109 7835205